Cytokinetics’ stock rockets to 19-year high after positive data on heart-disease treatment
Cytokinetics' stock rocketed Wednesday, after the cardiovascular-biopharmaceutical company announced positive results from a Phase 3 trial of aficamten, a treatment for hypertrophic cardiomyopathy.
11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria
These companies' expected free cash flow yields are at least double their current dividend yields.
IOTA’s ShimmerEVM integrates LayerZero for cross-chain communication
ShimmerEVM’s integration with LayerZero is expected to enhance cross-chain communication and DeFi on IOTA’s ShimmerEVM. Connectivity includes with Ethereum, Polygon, Avalanche, Binance Smart Chain and...
MicroStrategy boosts Bitcoin holdings with $615M purchase, eyes 1% of supply
MicroStrategy acquires 14,620 BTC for $615.7M, pushing total holdings to 189,150 BTC at $5.9B. CEO Michael Saylor remains bullish on Bitcoin, considering it the world’s...
BONK price sees 12% drop as Solana pares gains
Bonk (BONK) was trading 12% down as Solana (SOL) moved lower after its recent surge. An analyst says BONK could see a “slow bleed before...
SocialFi platform RepubliK integrates Fireblocks to enhance its Web3 security
RepubliK is a SocialFi platform for the creator economy in Web3, powered by native token RPK. The platform has integrated with Fireblocks, an institutional-graded blockchain...